ANIP
ANI Pharmaceuticals Inc
77.90$
-1.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -21.6% | +59.1% | +43.5% | +70.2% | -32.0% | -66.5% | -78.2% | -1,039.3% | – | -46.2% | +189.3% | |
| – | +77.9% | +223.8% | +25.0% | +20.8% | +32.2% | +0.1% | +5.9% | +26.2% | +0.2% | +13.3% | +35.0% | |
| – | +12.6% | +57.3% | +0.4% | +11.4% | +35.9% | +40.3% | -18.9% | +39.2% | +41.5% | +42.1% | +29.3% | |
| – | – | +90.2% | +174.7% | -67.7% | -27.1% | +58.3% | -195.6% | – | – | – | – | |
| – | – | – | – | – | -344.3% | – | – | – | – | -145.0% | – | |
| – | -8.6% | +356.1% | -27.6% | -89.9% | +152.5% | +148.0% | -65.4% | -30.4% | +12.5% | -8.4% | +102.4% | |
| – | -8.6% | +371.4% | -29.9% | -74.6% | +0.6% | +148.0% | +54.4% | -85.1% | +17.6% | +2,086.4% | -91.5% | |
| – | – | – | – | – | +2,920.0% | -89.2% | -69.3% | +755.3% | +0.0% | +0.0% | -28.8% | |
| – | -100.3% | +2,220.4% | -90.1% | +154.4% | +56.4% | +47.7% | -41.6% | +120.1% | +154.6% | +119.8% | +11.4% | |
| – | -45.7% | -100.4% | – | -140.0% | +319.7% | -99.6% | – | -103.0% | +0.0% | – | -102.9% | |
| – | -99.4% | -168.4% | – | -138.4% | – | -215.1% | – | -102.6% | – | +292.9% | -103.8% | |
| – | -109.1% | – | – | +214.0% | +62.7% | -381.9% | – | -156.3% | – | -145.4% | – | |
| – | – | – | – | – | -67.8% | -393.4% | – | – | – | -53.1% | +220.6% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.